Rubia S. Costa

Salvador, BA 40110160, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection.

Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection.

Journal: Emerging infectious diseases

Published: February 26, 2024

In Situ versus Systemic Immune Response in the Pathogenesis of Cutaneous Leishmaniasis.

In Situ versus Systemic Immune Response in the Pathogenesis of Cutaneous Leishmaniasis.

Journal: Pathogens (Basel, Switzerland)

Published: January 10, 2024

Assessment of Immune and Clinical Response in Patients with Mucosal Leishmaniasis Treated with Pentavalent Antimony and Pentoxifylline.

Assessment of Immune and Clinical Response in Patients with Mucosal Leishmaniasis Treated with Pentavalent Antimony and Pentoxifylline.

Journal: Tropical medicine and infectious disease

Published: August 30, 2022

High Anti-Leishmania IgG Antibody Levels Are Associated With Severity of Mucosal Leishmaniasis.

High Anti-Leishmania IgG Antibody Levels Are Associated With Severity of Mucosal Leishmaniasis.

Journal: Frontiers in cellular and infection microbiology

Published: January 13, 2021

Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis.

Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 01, 2020

Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis.

Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis.

Journal: Journal of immunology research

Published: March 19, 2020

Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Journal: The Journal of infectious diseases

Published: January 30, 2020

Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis.

Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis.

Journal: The Journal of infectious diseases

Published: June 12, 2019

Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy.

Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy.

Journal: The Journal of infectious diseases

Published: August 29, 2017

Cytotoxic activity in cutaneous leishmaniasis.

Cytotoxic activity in cutaneous leishmaniasis.

Journal: Memorias do Instituto Oswaldo Cruz

Published: March 16, 2017

Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections.

Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections.

Journal: The Journal of infectious diseases

Published: August 21, 2014

A Potential Role for Mononuclear Phagocytes in Cutaneous Ulcer Development in Human Immunodeficiency Virus-Leishmania braziliensis Coinfection.

A Potential Role for Mononuclear Phagocytes in Cutaneous Ulcer Development in Human Immunodeficiency Virus-Leishmania braziliensis Coinfection.

Journal: The American journal of tropical medicine and hygiene

Published: July 30, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026